Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference

Myomo (MYO) will participate in the 17th Annual Craig Hallum Alpha Select Conference on November 17, 2026, in New York.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the 17^th Annual Craig Hallum Alpha Select Conference being held Tuesday, November 17, 2026, at the Sheraton New York Times Square Hotel. Myomo’s President and Chief Executive Officer Paul Gudonis, Chief Financial Officer David Henry and Chief Commercial Officer Katie McClure will participate in one-on-one meetings throughout the event.

Investors interested in scheduling a meeting with the Company should contact their Craig Hallum representative.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20261103940274/en/

Myomo
ir@myomo.com

Alliance Advisors IR
Vivian Cervantes
vcervantess@allianceadvisors.com
973-873-7724

Source: Myomo, Inc.

Key Terms

orthosis medical

A orthosis is a medical device—such as a brace, splint, shoe insert or support—worn outside the body to support, align, protect or improve the function of a limb or the spine. For investors it signals a part of the healthcare equipment market tied to durable product sales, reimbursement rules, regulatory approvals and ongoing demand from hospitals, clinics and patients; changes in coverage, technology or aging demographics can affect revenue and profit outlooks for companies that make or supply them.

emg signals medical

Electrical recordings of muscle activity captured by electrodes; EMG signals show the timing and relative intensity of muscle fiber depolarizations either at the skin surface (surface EMG) or from within the muscle (intramuscular EMG). They are processed with amplification and filtering because raw signals include noise and do not directly measure force—amplitude and frequency patterns are interpreted to infer muscle activation, fatigue, or nerve function but require careful setup and analysis to avoid artifacts and cross-talk from nearby muscles.